Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Binhan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Cartilage, Articular, Inflammation, Nanotechnology, Osteoarthritis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Cooperation Program of Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Osteoarthritis (OA) is among the most prevalent degenerative joint disorders worldwide, particularly affecting the aging population and imposing significant disability and economic burdens. The disease is characterized by progressive degradation of articular cartilage and chronic inflammation, with no effective long-term treatments currently available to address the underlying causes of its progression. Conventional therapies primarily manage symptoms such as pain and inflammation but fail to repair damaged tissues. Emerging biotherapies and regenerative medicine approaches offer promising alternatives by addressing cartilage repair and inflammation control at the molecular level. This review explores the recent advancements in biotherapeutic strategies, including mesenchymal stem cell (MSC) therapy, growth factors, and tissue engineering, which hold the potential for promoting cartilage regeneration and modulating the inflammatory microenvironment. Additionally, the integration of nanotechnology has opened new avenues for targeted drug delivery systems and the development of innovative nanomaterials that can further enhance the efficacy of biotherapies by precisely targeting inflammation and cartilage damage. This article concludes by discussing the current clinical applications, the ongoing clinical trials, and the future research directions necessary to confirm the safety and efficacy of these advanced therapies for OA management. With these advancements, biotherapies combined with nanotechnology may revolutionize the future of OA treatment by offering precise and effective solutions for long-term disease management and improved patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu 610041, China.
Förderung
- International Cooperation Program of Science and Technology Department of Sichuan Province
Zitieren
APA
Liu, B., Liu, T., Li, Y., & Tan, C. (2024). Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413384
Vancouver
Liu B, Liu T, Li Y, Tan C. Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413384
BibTeX
@article{Liu2024,
author = {Liu, Binhan and Liu, Tao and Li, Yanhong and Tan, Chunyu},
title = {Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413384}
}
EUVIMED